Clinical Trials UpdateCT.govClinical TrialFriday, May 29, 2026
Identifying Biological Markers of Cardiovascular Events in Patients With Aortic Stenosis or TAVI
3 min read·By E. Nolan Beckett, MD·Source: ClinicalTrials.gov
Clinical Trial Profile
NCT
NCT06713889
Phase
N/A
Status
RECRUITING
Sponsor
Hospices Civils de Lyon
Read the Original
Full article at ClinicalTrials.gov
Open at ClinicalTrials.gov →The Valve Wire summarizes; we link out to primary sources for verification.
More in Clinical Trials Update
- Clinical Trials Update· ClinicalTrials.govREdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
- Clinical Trials Update· ClinicalTrials.govReal World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation
- Clinical Trials Update· ClinicalTrials.govNHLBI-Emory Advanced Cardiac CT Reconstruction
Elsewhere in Today’s Issue
- Aortic Valve (TAVR/TAVI)· TCTMD.comLANDMARK: 2-Year Data Show Continued Safety and Efficacy of Unique TAVI Valve - TCTMD.com
- Aortic Valve (TAVR/TAVI)· Cardiovascular BusinessThe high costs of robotic tech | Medtronic recalls thousands of devices | TAVR in younger patients | FDA approves next-gen valve - Cardiovascular Business
- Aortic Valve (TAVR/TAVI)· CNBCJosh Brown's 'best stocks in the market': Edwards Lifesciences - CNBC